Skip to content

   Pharma Publications

Neuropsychopharmacology
  • To indulge or enrich: how environmental enrichment affects neurons that promote food seeking
    Published on 2025-07-04
    11 months ago
  • Impact of early social isolation on social circuits and behavior: relevance to schizophrenia
    Published on 2025-07-04
    11 months ago
  • Prefrontal cortex development and its implications in mental illness
    Published on 2025-07-03
    11 months ago
  • High hopes, hard realities: cannabidiol shows no acute effects in youth with alcohol use disorder
    Published on 2025-07-03
    11 months ago
  • Targeting inhibitory control in youth irritability: challenges and opportunities
    Published on 2025-07-01
    11 months ago
  • Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study
    Published on 2025-06-30
    11 months ago
  • Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors
    Published on 2025-06-27
    11 months ago
« Previous 1 … 40 41 42 43 44 … 143 Next »
Journal of Psychopharmacology
  • Voluntary nicotine consumption and reward in a subset of diversity outbred founder strains
    Published on 2024-08-13
    2 years ago
  • Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire
    Published on 2024-08-13
    2 years ago
  • Adult rat ultrasonic vocalizations and reward: Effects of propranolol and repeated cocaine administration
    Published on 2024-08-12
    2 years ago
  • Insomnia and the effect of zolpidem-extended-release on the sleep items of the Hamilton Rating Scale for Depression in outpatients with depression, insomnia, and suicidal ideation: Relationship to patient age
    Published on 2024-08-09
    2 years ago
  • Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers
    Published on 2024-08-09
    2 years ago
  • Re-visiting the association between antidepressant use and the risk of lung cancer
    Published on 2024-08-09
    2 years ago
  • Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder
    Published on 2024-08-09
    2 years ago
« Previous 1 … 40 41 42 43 44 … 145 Next »
European Neuropsychopharmacology
  • Childhood maltreatment: A call for a standardised definition and applied framework
    Published on 2024-07-18
    2 years ago
  • Deciphering the impact of metabolic anomalies in relation to severe mental illness
    Published on 2024-07-17
    2 years ago
  • Mixed features in mood episodes: Mismatch between intensity and valence in emotional responses
    Published on 2024-07-17
    2 years ago
  • Ketamine and new targets for treatment-resistant depression: A role for transforming growth factor-β1?
    Published on 2024-07-17
    2 years ago
  • Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis
    Published on 2024-06-29
    2 years ago
  • Shared vulnerability and sex-dependent polygenic burden in psychotic disorders
    Published on 2024-06-28
    2 years ago
  • Gray matter volumetric correlates of the polygenic risk of depression: A study of the Human Connectome Project data
    Published on 2024-06-27
    2 years ago
« Previous 1 … 40 41 42 43 44 … 166 Next »

   Pharma Pub